Identification of Rat Prostatic Steroid-Binding Protein as a Target Antigen of Experimental Autoimmune Prostatitis: Implications for Prostate Cancer Therapy

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 472-480

  Liu, Ko Jiunn ^a   Chatta, Gurkamal S ^a   Twardzik, Daniel R ^a,b   Vedvick, Thomas S ^c   True, Lawrence D ^a   Gregory Spies, A ^a   Cheever, Martin A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; PROTEIN; STEROID;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNIZATION; IMMUNOLOGY; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; LEWIS RAT; MALE; METABOLISM; PROSTATE TUMOR; PROSTATITIS; RAT;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IMMUNIZATION; IMMUNOTHERAPY; MALE; PROSTATIC NEOPLASMS; PROSTATITIS; PROTEINS; RATS; RATS, INBRED LEW; STEROIDS;

EID: 0031179125     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Parker, S. L., T. Tong, S. Bolden, and P. A. Wingo. 1996. Cancer statistics, 1996 [see comments]. CA Cancer J. Clin. 46:5.
2. Tannock. I. F., D. Osoba, M. R. Stockler, D. S. Ernst, A. J. Neville, M. J. Moore, G. R. Armitage, J. J. Wilson, P. M. Venner, C. M. L. Coppin, and K. C. Murphy. 1996. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J. Clin. Oncol. 14:1756.
3. Mulders, T. M., P. F. Bruning, and J. M. Bonfrer. 1990. Prostate-speciric antigen (PSA). A tissue-specific and sensitive tumor marker. Eur. J. Surg. Oncol. 16:37.
4. Malm, J., and H. Lilja. 1995. Biochemistry of prostate specific antigen, PSA. Scand. J. Clin. Lab. Invest. 55(Suppl. 221):15.
5. Troyer, J. K., M. L. Beckett, and G. L. Wright, Jr. 1995, Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer 62:552.
6. Israeli, R. S., C. T. Powell, W. R. Fair, and W. D. W. Heston. 1993. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 53:227.
7. Hodge, J. W., J. Schlom, S. J. Donohue, J. E. Tomaszewski, C. W. Wheeler, B. S. Levine, L. Gritz, D. Panicali, and J. A. Kantor. 1995. A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and immunogenicity in a non-human primate. Int. J. Cancer 63:231.
8. Tjoa, B., A. Boynton, G. Kenny, H. Ragde, S. L. Misrock, and G. Murphy. 1996. Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity. Prostate 28:65.
9. Depiante-Depaoli, M., B. Pacheeo-Rupil, S. Britos, and A. Casas. 1984. Experimental autoimmune damage to rut male accessory glands. I. Transfer of autoimmune response by spleen cells. Am. J. Reprint. Immunol. 5:9.
10. Pacheco-Rupil, B., M. Depiante-Depaoli, and B. Casadio. 1984. Experimental autoimmune damage to rat male accessory glands. II. T cell requirement in adoptive transfer of specific tissue damage. Am. J. Reprod. Immunol. 5:15.
11. Depiante-Depaoli, M., and B. Pacheco-Rupil. 1985. Experimental autoimmunity to rat male accessory glands (MAG): circulating antibodies. immunoglobulins bound to target glands, and immunoglobulins-secreting cells. Am. J. Reprod. Immunol. Microbiol. 7:32.
12. Casas-Ingaramo, A., M. Depiante-Depaoli, and B. Pacheco-Rupil. 1991. Activation of cytotoxic cells by syngeneic prostate antigens in experimental autoimmune vesiculo-prostatitis. Autoimmunity 9:151.
13. Keeteh, D. W., P. Humphrey, and T. L. Ratliff. 1994. Development of a mouse model for nonbacterial prostatitis [see comments]. J. Urol. 152:247.
14. Taguchi, O., A. Kojima, and Y. Nishizuka. 1985. Experimental autoimmune prostititis after neonatal thymectomy in the mouse. Clin. Exp. Immunol. 60:123.
15. Forsgren, B., P. Bjork, K. Carlstrom, J. A. Gustafsson, A. Pousettc, and B. Hogberg. 1979. Purification and distribution of a major protein in rat prostate that binds estramustine. a nitrogen mustard derivative of estradiol-17 beta. Proc. Natl. Acad. Sci. USA 76:3149.
16. Liao, S., C. Chen, and I. Y. Huang. 1982. Prostate alpha-protein. Complete amino acid sequence of the component that inhibits nuclear retention of the androgen-receptor complex. J. Biol. Chem. 257:122.
17. Bichler, K. H., S. H. Fluchter, H. J. Neide, P. Bjork, and J. Muntzing. 1989. An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate. Prostate 14:13.
18. Forsgren, B., B. Hogberg, J. A. Gustafsson, and A. Pousette. 1978. Binding of estramustine, a nitrogen mustard derivative of estradiol-17 beta, in cytosol from rat ventral prostate. Acta Pharm. Suec. 15:23.
19. 3H]-estramustine in the rat ventral prostate. Acta Pharmacol. Toxicol. 43:368.
20. Forsgren, B., J. A. Gustafsson, A. Pousette, and B. Hogberg. 1979. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol. Cancer Res. 39:5155.
21. Perry, C. M., and D. McTavish. 1995. Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer. Drugs Aging 7:49.
22. Pienta, K. J., B. Redman, M. Hussain, G. Cummings, P. S. Esper, C. Appel, and L. E. Flaherty. 1994. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate [see comments]. J. Clin. Oncol. 12:2005.
23. Nilsson, T., and J. Muntzing. 1973. Hislochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt. Scand. J. Urol. Nephrol. 7:18.
24. Shiina, H., T. Ishibe, and T. Usui. 1991. Immunoreactive protein to rat estramustine binding protein in human seminal plasma: its relationship to prostatic acid phosphatase and zinc. Andrologia 23:177.
25. Shiina, H., M. Mizutani, and T. Ishibe. 1990. Estramustine binding protein in human benign prostatic hypertrophy. Andrologia 22:309.
26. de-la-Torre, M., S. Eklov, M. Haggman, P. Bjork, C. Busch, and S. Nilsson. 1994. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia. Prostate 25:125.
27. Cheever, M. A., P. D. Greenberg, A. Fefer, and S. Gillis. 1982. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J. Exp. Med. 155:968.
28. Cheever, M. A., D. B. Thompson, J. P. Klarnet, and P. D. Greenberg. 1986. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells. J. Exp. Med. 163:1100.
29. Brown, R. C., and H. C. Hopps. 1973. Staining of bacteria in tissue sections: a reliable gram stain method. Am. J. Clin. Pathol. 60:234.
30. Yuasa, H., H. Yamanaka, K. Imai, T. Mashimo, and H. Kohno. 1990. Purification of 45 KDa estramustine binding protein (EMBP) and preparation of its antibody. Hinyokika Kiyo 36:121.
31. Bjork, P., U. Jonsson, and A. Andr'en-Sandberg. 1991. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyl) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein. Pancreas 6:77.
32. Peeters, B., W. Rombauts, J. Mous, and W. Heyns. 1981. Structural studies on rat prostatic binding protein: the primary structure of its glycosylated component C3. Eur. J. Biochtm. 115:115.
33. Peeters, B., W. Heyns, J. Mous, and W. Rombauts. 1983. Structural studies on rat prostatic binding protein: the primary structure of component C2 from subunit S. Eur. J. Biochem. 132:669.
34. Peeters, B., W. Heyns, J. Mous, and W. Rombauts. 1982. Structural studies on rat prostatic binding protein: the primary structure of component C1 from subunit F. Eur. J. Biochem. 123:55.
35. Pesoa, S. A., M. C. Pistoresi-Palencia, M. Galmarini, E. Vottero-Cima, and C. M. Riera. 1983. Isolation of rat male accessory glands autoantigens by affinity chromatography. Am. J. Reprod. Immnnol. 4:67.
36. Galmarini, M., H. M. Serra, M. C. Pistoresi-Palencia, E. Vottero-Cima, and C. M. Riera. 1986. Production of rat male accessory gland lesions by transfer of spleen mononuclcar cells. Cell. Mol. Biol. 32:293.
37. Emoto, M., E. Kita, F. Nishikawa, N. Katsui, Y. Yagyu, and S. Kashiba. 1990. Biological functions of mouse seminal vesicle fluid. 1. Suppression of blustogenic responses of lymphocytes. Arch. Androl. 24:35.
38. Emoto, M., F. Nishikawa, A. Hamuro, D. Oku, E. Kita, and S. Kashiba. 1991. Biological functions of the water-insoluble fraction of mouse seminal vesicle fluid. 1. Suppression of the blastogenic response of lymphocytes. Int. J. Androl. 14:196.
39. Kelly, R. W., P. Holland, G. Skibinski, C. Harrison, L. McMillan, T. Hargreave, and K. James. 1991. Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin. Exp. Immunol. 86:550.
40. Peluso, G., R. Porta, C. Esposito, M. A. Tufano, R. Toraldo, M. L. Vuotto, G. Ravagnan, and S. Metafora. 1994. Suppression of rat epididymal sperm immunogenicity by a seminal vesicle secretory protein and transglutuminase both in vivo and in vitro. Biol. Reprod. 50:593.
41. Shulmun, S., E. J. Brandt, and C. Yantorno. 1968. Studies in cryo-immunology. II. Tissue and species specificity of the autoantibody response and comparison with iso-immunization. Immunology 14:149.
42. Shulman, S., P. Bronson, C. Riera, E. J. Brandt and C. Yantorno. 1968. Studies in cryo-immunolugy. III. The immunoglobulin nature of the antibody response. Immunology 14:541.
43. Yantorno, C., W. A. Souries, M. J. Gonder, and S. Shulman. 1967. Studies in cryo-immunology. I. The production of antibodies to urogenital tissue in consequence of freezing treatment. Immunology 12:395.
44. Pesoa, S. A., M. Galmarini, M. C. Pistoresi-Palencia, and C. M. Riera. 1986. Characterisation of an antigen from rat male accessory glands. Int. Arch. Allergy Appl. Immunol. 79:19.
45. Wegmann, K. W., W. Zhao, A. C. Griffin, and W. F. Hickey. 1994. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat: the utility of a class II binding motif in selecting self-reactive peptides. J. Immunol. 153:892.
46. Shiinu, H., H. Sumi, T. Ishibe, and T. Usui. 1944. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue. Urol. Int. 52:213.
47. Yuasa, H., T. Suzuki, K. Imai, H. Yamanaka, and H. Kohno. 1991. Dependency of estrumustine binding protein (EMBP) from rat prostate to endogenous androgen. Nippon Naibunpi Gakkai Zasshi 67:645.
48. Milich, D. R., A. McLachlan, A. K. Raney, R. Houghten, G. B. Thornton, T. Maruyama, J. L. Hughes, and J. E. Jones. 1991. Autoantibody production in hepatitis B e antigen tranvgenic mice elicited with a self T cell peptide and inhibited with nonself peptides. Proc. Natl. Acad. Sci. USA 88:4MN.
49. Cibotti, R., J. M. Kanellopoulos, J. P. Cahaniols, O. Halle-Panenko, K. Kosmatopoulos, E. Sercarz, and P. Kourilsky. 1992. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl. Acad. Sci. USA 89:416.
50. Ochen, S. U., P. S. Ohashi, K. Burki, H. Hengartner, R. M. Zinkernagel, and P. Aichcle. 1994. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell. Immunol. 158:342.
51. Hartley-Asp, B. 1984. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3. Prostate 5:93.
52. Eklov, S., A. Larson, P. Bjork, and S. Nilsson. 1992. The expression of estramustine-binding protein in the human prostatic cancer cell line DU 145 is not androgcn dependent. Scand. J. Urol. Nephrol. 26:119.